Publications by authors named "Alexandre Brito Cosimo"
Reply to Comment on: Long-term Results of Trimethoprim Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrent Toxoplasma gondii Retinochoroiditis.
Am J Ophthalmol
December 2020
Long-term Results of Trimethoprim-Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrent Toxoplasma gondii Retinochoroiditis.
Am J Ophthalmol
May 2020
Purpose: To compare the effects of 1 year of treatment with trimethoprim-sulfamethoxazole (TMP-SMZ) vs placebo in reducing the risk of recurrence of toxoplasmic retinochoroiditis during a 6-year follow-up period.
Design: Randomized, double-masked clinical trial.
Methods: This cohort included 141 subjects recruited in Campinas, Brazil.
Trimethoprim-Sulfamethoxazole Versus Placebo in Reducing the Risk of Toxoplasmic Retinochoroiditis Recurrences: A Three-Year Follow-up.
Am J Ophthalmol
October 2016
Purpose: To compare the effects of 1 year of treatment with trimethoprim/sulfamethoxazole (TMP-SMZ) vs a placebo in reducing the risk of toxoplasmic retinochoroiditis recurrences during a 3-year follow-up period.
Design: Randomized, double-masked clinical trial.
Methods: This cohort included 141 volunteers recruited in Campinas, Brazil.